Webinvestigate the drug (21 CFR 312.53(a)). In the event the clinical investigator is a non- physician, a qualified physician (or dentist, when appropriate) should be listed as a WebJan 17, 2024 · Sec. 312.64 Investigator reports. (a) Progress reports. The investigator shall furnish all reports to the sponsor of the drug who is responsible for collecting and evaluating the results obtained. The sponsor is required under § 312.33 to submit annual reports to FDA on the progress of the clinical investigations.

eCFR :: 31 CFR 1010.312 -- Identification required.

Web2 days ago · information in 21 CFR part 312 have been approved under OMB control number 0910–0014; the collections of information in 21 CFR part 812 have been approved under OMB control number 0910–0078; the collections of information in 21 CFR part 11 have been approved under OMB control number 0910–0303; and the collections of Web§ 121.312 Materials for compartment interiors. 14 CFR § 121.312 - Materials for compartment interiors. ... an airplane that conforms to an amended or supplemental type … interval exception arise

Safety Reporting Requirements for INDs and BA/BE Studies

WebNomenclature changes to part 312 appear at 69 FR 13717, Mar. 24, 2004. § 312.59 Disposition of unused supply of investigational drug. The sponsor shall assure the return of all unused supplies of the investigational drug from each individual investigator whose participation in the investigation is discontinued or terminated. WebJul 25, 2013 · Consumer Protection Privacy and Security Children's Privacy 16 CFR Part 312 Children's Online Privacy Protection Act of 1998, 15 U.S.C. 6501–6505 Children's Privacy Rule Summary Web2 47 CFR § 73.3539(a). 3 Id. Federal Communications Commission DA 23-312 2 ... forfeiture penalty.7 Section 312(f)(1) of the Act defines willful as “the conscious and deliberate commission or omission of [any] act, irrespective of any … new gopro accessories 2015